Life Science News

Maple, Cloud DX and Curatio Announce Canada-Wide COVID-19 Home Monitoring Program

Cloud DX (TSXV:CDX) a leading Canadian provider of virtual care and remote patient monitoring solutions announced today it is joining forces with fellow virtual care providers Maple and Curatio to create a new Canada-wide COVID-19 home monitoring program that will allow Canadian healthcare organizations to ‘decant' COVID-19 patients to their homes equipped with remote automated monitoring technology, efficient clinical oversight and daily disease management support via virtual care

The Canada-wide Virtual COVID-19 Outpatient Program (VCOP) brings together three core elements into one integrated COVID-19 virtual care program:

  • Key vital signs monitoring via Cloud DX's Connected Health Kit (wireless pulse oximeter, wireless thermometer, the Pulsewave™ blood pressure cuff, Cloud DX mobile app and clinical portal).

  • Clinical oversight from Canadian-licensed physicians on the Maple virtual care platform, to monitor patient vital signs, triage patient condition and make treatment recommendations should COVID-19 symptoms worsen.

  • Coaching and support through Curatio's Stronger Together secure, moderated support network to connect patients to daily evidence-based programs, community resources, mental health and psychosocial support.

"We're at a critical stage right now, especially with new variants of concern which are exacerbating the resource challenges that hospitals are already facing," says Brett Belchetz, CEO and Co-founder, Maple. "We're pleased to partner on this innovative remote patient monitoring program to support healthcare facilities in coping with the influx of COVID-19 patients."

"As CEOs of three of Canada's most prominent virtual care companies, we cannot stand by as our country battles the worst health crisis in a century. It was critically important to all of us to find a solution to mitigate the potential human catastrophe we see unfolding in our hospitals," says Robert Kaul, CEO of Cloud DX. "We are actively petitioning Provincial health ministries, starting with Ontario Health, for VCOP adoption for a minimum of 90 days to help healthcare providers manage through this third wave crisis."

"We already have thousands of patients with long COVID benefiting from our platform along with patients awaiting surgery, battling chronic conditions and mental health challenges," says Lynda Brown-Ganzert, CEO of Curatio. "We are a Canadian-made answer, ready to be deployed to help ease this COVID-19 crisis. As leaders, we have quickly banded together to help support our healthcare systems, authorities, government and most importantly, our fellow Canadian patients and families. Our solutions are trusted worldwide and it's time to utilize them, right here at home, for the urgent challenges we face."

"Virtual care and remote home monitoring are game changers when it comes to how we care for patients," says Dr. Mohamed Panju, site chief for HHS Hamilton General Hospital, where one of the hospital's COVID units is located. Dr. Panju is also a physician lead for the remote home monitoring program at HHS. "Remote home monitoring creates a safety net for patients recovering at home and it helps prevent return trips to the emergency department since the virtual care team can help with health concerns that might arise," he said.

Cloud DX, Maple and Curatio have agreed to share revenues earned under this joint program, wherein each company will offer best available pricing. Cloud DX has many commercial deployments of the Connected health System in Canada, including contracts with Provincial and Territorial governments, hospital systems in Ontario and Alberta and commercial partners. The Curatio platform is used in 104 countries, is available in 20 languages, and is the only privacy and regulatory compliant social platform for patients. Maple is Canada's industry leading virtual care platform, supporting multiple hospitals across the Greater Toronto Area with COVID-19 response virtual care programs.

About Maple

Maple is a technology platform that tackles some of the world's most meaningful issues in healthcare, starting with timely and convenient access to doctors and other healthcare providers including dermatologists, psychiatrists, and oncology navigation experts. It allows patients to connect directly with doctors and specialists for medical care in minutes from their smartphone or computer 24/7, and also provides custom technology solutions for employers, insurers, hospitals, and clinics. Learn more at

About Cloud DX

Accelerating virtual healthcare's future Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist and one of Canada's 10 most prominent Telehealth providers.

For More Information on Cloud DX - Join Us on Zoom Today - Register Here

About Curatio

Curatio enables payers, providers, researchers and pharmaceutical manufacturers to compliantly engage with patients on their own social networks. Curatio provides a private, secure social network platform that uses proprietary algorithms, AI and machine learning to match patients to the peer support, programs and daily management tools that help them live their healthiest lives. Used in 104 countries, available in 20 languages, Curatio has won numerous awards for its unique technical solution and its mission of No Patient Alone. Download the Stronger Together app at

# # #

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For media inquiries please contact:

Aliya Darvesh
Senior Manager Communications, Maple

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)

For Cloud DX investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations

For More Information on Cloud DX - Join Us on Zoom Today, April 28, 2021 at 2pm EST - Register Here:

Valerie Stachurski
Brand Manager, Curatio Networks Inc.

SOURCE:Cloud DX Inc.

View source version on

News Provided by ACCESSWIRE via QuoteMedia

dynaCERT Announces Auditor Resignation

dynaCERT Announces Auditor Resignation

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") announces the resignation of its auditors, BDO Canada LLP ("BDO"). BDO resigned on their own initiative, which resignation has been reviewed by dynaCERT 's audit committee. BDO has advised that its resignation is a business decision of such firm and has confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 Continuous Disclosure Obligations ) in connection with the change of auditor. dynaCERT is commencing the process to engage a replacement auditor for the 2022 fiscal year.

About dynaCERT Inc.
dyna CERT Inc. manufactures and distributes Carbon Emission Reduction Technology for use with internal combustion engines. As part of the growing global hydrogen economy, our patented technology creates hydrogen and oxygen on-demand through a unique electrolysis system and supplies these gases through the air intake to enhance combustion, resulting in lower carbon emissions and greater fuel efficiency. Our technology is designed for use with many types and sizes of diesel engines used in on-road vehicles, refrigerated trailers, off-road construction, power generation, mining and forestry equipment, marine vessels and railroad locomotives. Website: .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results

Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results


nano one® Materials Corp. ("nano one" or the "Company") is a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries. nano one has filed its unaudited condensed interim consolidated financial statements (the "financial statements") and management's discussion & analysis for the second fiscal quarter ended June 30, 2022 and is pleased to provide the following highlights from Q2 2022.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that it has secured an exclusive license from University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a biologic agent for the treatment of cancer.

The novel technology, originally developed by Suzanne Ostrand-Rosenberg, Ph.D., Emeritus Faculty at UMBC, and member of BriaCell's scientific advisory board, is titled "Soluble CD80 as a Therapeutic to Reverse Immune Suppression in Cancer Patients" and covered under USPN 8,956,619 B2 , USPN 9,650,429 B2 , and USPN 10,377,810 B2 . In animal models, sCD80 was well-tolerated and stopped tumor growth by potentially restoring natural anti-tumor immunity (see Lucas A Horn, et al . and Samuel T Haile et al. in collaboration with Dr. Ostrand-Rosenberg). Additionally, strong anti-tumor activity of sCD80 has been reported in multiple tumor types (see Lucas A Horn, et al .). Importantly, as demonstrated in the same studies, sCD80's unique actions may involve both awakening and boosting the immune system to recognize and destroy tumor cells.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

Four Brands from Two Global CPG Conglomerates Leverage Patented Data and Analytics PaaS for Analysis of Digital Advertising Sponsorships During Top Broadcasted Sporting Event in North America

DGTL Holdings Inc. (TSXV: DGTL) ("DGTL" or the "Company") is pleased to announce that its wholly owned subsidiary Engagement Labs has secured four new PaaS (Platform-as-a-Service) contracts from two global consumer packaged goods (CPG) conglomerates.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Nano One Announces Results of Annual General Meeting

Nano One Announces Results of Annual General Meeting

nano one ® Materials Corp. (TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB) (the "Company"), a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries, is pleased to announce the results of the annual general meeting of shareholders adjourned July 26, 2022, and reconvened today in Vancouver, British Columbia (the " Meeting

A total of 24,138,258 common shares were represented at the Meeting, representing 25.25% of the total issued and outstanding common shares of the Company.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Naturally Splendid Announces Proposed Consolidation and Special Meeting

Naturally Splendid Announces Proposed Consolidation and Special Meeting

Naturally Splendid Enterprises Ltd. ("Naturally Splendid" or "NSE" or the "Company") (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) announces that it intends to consolidate its issued and outstanding common shares at a ratio of up to fifteen (15) pre-consolidation shares to one (1) post-consolidation share (the "Consolidation"). The purpose of the Consolidation is to facilitate the Company's ability to attract future financings, generate greater investor interest, and improve trading liquidity

The Company currently has 330,624,458 common shares issued and outstanding. In the event the Company proceeds with the Consolidation, as opposed to a lesser ratio, the Company anticipates there would be 22,041,631 common shares issued and outstanding.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News